Opana is the brand name for oxymorphone, which is an opioid analgesic prescribed to treat moderate to severe pain. It is chemically similar to morphine, which makes it a choice drug to treat serious pain after surgery or due to illness or injury. Injectable and extended-release formulas of oxymorphone were approved by the Food and Drug Administration (FDA) under the Opana brand name in 2006. However, that also means it has a high potential for addiction and abuse, which is why the Drug Enforcement Administration (DEA) has listed Opana as a Schedule II medication.
People who struggle with Opana addiction often crush the pills and snort them, or mix them with water to inject. This almost instantly flushes the body with opioid drugs versus the wait required when the drugs are swallowed, as they move slowly through the digestive system. The manufacturer, Endo Pharmaceuticals, has attempted to create an “abuse-proof” version of the medication, but people continue to abuse the narcotic painkiller.